This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 3.39 points to 1,005.58 Friday, ending the week up 9.80 points. On Monday, two licensed producers of medical marijuana, Bedrocan Canada Ltd. and OrganiGram Inc., will list on the TSX-V.

Bedrocan will list on Monday through Pat DiCapo's capital pool shell, POCML 2 Inc. (PCC). The shell has changed its name to Bedrocan Cannabis Corp. and will resume trading under symbol BED. POCML 2 rolled back its shares 1:2, leaving it with three million postconsolidated shares, and issued 64.5 million postconsolidated shares to Bedrocan shareholders. The largest shareholder of Bedrocan Cannabis is a Toronto real estate developer, 84-year-old Murray Goldman, with 9,668,750 shares. Marc Wayne, a businessman and marijuana lobbyist, is Bedrocan's chief executive officer and the second-largest shareholder with 6,977,867 shares. Another large shareholder is Tjalling Erkelens with 6,856,750 shares. He is the founder of Bedrocan Beheer BV, the Dutch government-appointed sole supplier of medical marijuana to pharmacies in the Netherlands. His Bedrocan Beheer also ships its product overseas to Mr. Wayne's Bedrocan Cannabis, and will continue to do so until April, 2015. By then, Bedrocan Cannabis hopes to be selling medical marijuana from a $10-million 52,000-square-foot facility that it plans to build in the greater Toronto area.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS